Most Recent Jobs
Post an Event
Biosystems Inc. (TSX-V: MBX) is a biotechnology company
leveraging its long-standing core virology business to develop products
targeted to large global market opportunities.
has taken a core virology business and used the proceeds this business has
generated over the years and applied them to develop or acquire high-potential,
large-market products to serve a variety of health-science segments. Microbix
has reached the point where a large-market development product has made
substantial progress in moving towards realization. The Company is now at the
threshold and about to reap the benefits.
strong growth opportunities in large markets, Microbix is ready to make the
break-through in realizing on its long-term vision. Our 12-month Target Price of
$1.15 per share reflects our expectations that the Company will achieve its
the complete Initiating Report, click here: http://www.eresearch.ca/_report/MBX_070711-I.pdf.
eResearch posts all its reports and
articles on its website, www.eresearch.ca,
and subscription is FREE.
About Us: eResearch is a primary source for professional investment research,
focused primarily on small- and mid-cap companies. Our research and analysis is
of institutional quality, and has the potential for reaching millions of global
investors through our extensive electronic distribution network.
eResearch: Bob Weir, CFA, Managing Director,
(416) 703-6258 Ext 221; E-mail: firstname.lastname@example.org